<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Commun</journal-id><journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id><journal-title-group><journal-title>Nature Communications</journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5840367</article-id><article-id pub-id-type="publisher-id">3252</article-id><article-id pub-id-type="doi">10.1038/s41467-018-03252-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Genome-wide analysis yields new loci associating with aortic valve stenosis </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1806-2467</contrib-id><name><surname>Helgadottir</surname><given-names>Anna</given-names></name><address><email>anna.helgadottir@decode.is</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Thorleifsson</surname><given-names>Gudmar</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gretarsdottir</surname><given-names>Solveig</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Stefansson</surname><given-names>Olafur A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tragante</surname><given-names>Vinicius</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Thorolfsdottir</surname><given-names>Rosa B.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jonsdottir</surname><given-names>Ingileif</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Bjornsson</surname><given-names>Thorsteinn</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Steinthorsdottir</surname><given-names>Valgerdur</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Verweij</surname><given-names>Niek</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6654-2852</contrib-id><name><surname>Nielsen</surname><given-names>Jonas B.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Folkersen</surname><given-names>Lasse</given-names></name><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Martinsson</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Heydarpour</surname><given-names>Mahyar</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Prakash</surname><given-names>Siddharth</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Oskarsson</surname><given-names>Gylfi</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Gudbjartsson</surname><given-names>Tomas</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name><surname>Geirsson</surname><given-names>Arnar</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Olafsson</surname><given-names>Isleifur</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Sigurdsson</surname><given-names>Emil L.</given-names></name><xref ref-type="aff" rid="Aff16">16</xref><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0473-0241</contrib-id><name><surname>Almgren</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="Aff18">18</xref><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name><surname>Melander</surname><given-names>Olle</given-names></name><xref ref-type="aff" rid="Aff18">18</xref><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name><surname>Franco-Cereceda</surname><given-names>Anders</given-names></name><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name><surname>Hamsten</surname><given-names>Anders</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Fritsche</surname><given-names>Lars</given-names></name><xref ref-type="aff" rid="Aff21">21</xref><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Maoxuan</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="Aff23">23</xref><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Hornsby</surname><given-names>Whitney</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Dongchuan</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Brummett</surname><given-names>Chad M.</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Abecasis</surname><given-names>Gonçalo</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Mathis</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Milewicz</surname><given-names>Dianna</given-names></name><xref ref-type="aff" rid="Aff11">11</xref><xref ref-type="aff" rid="Aff27">27</xref></contrib><contrib contrib-type="author"><name><surname>Body</surname><given-names>Simon C.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Eriksson</surname><given-names>Per</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5645-4966</contrib-id><name><surname>Willer</surname><given-names>Cristen J.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff24">24</xref><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name><surname>Hveem</surname><given-names>Kristian</given-names></name><xref ref-type="aff" rid="Aff21">21</xref><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Newton-Cheh</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff29">29</xref><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>J. Gustav</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Danielsen</surname><given-names>Ragnar</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name><surname>Thorgeirsson</surname><given-names>Gudmundur</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name><surname>Thorsteinsdottir</surname><given-names>Unnur</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Gudbjartsson</surname><given-names>Daniel F.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name><surname>Holm</surname><given-names>Hilma</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Stefansson</surname><given-names>Kari</given-names></name><address><email>kstefans@decode.is</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>deCODE genetics/Amgen Inc., Reykjavik, 101 Iceland </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0640 0021</institution-id><institution-id institution-id-type="GRID">grid.14013.37</institution-id><institution>Faculty of Medicine, </institution><institution>University of Iceland, </institution></institution-wrap>Reykjavik, 101 Iceland </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9558 4598</institution-id><institution-id institution-id-type="GRID">grid.4494.d</institution-id><institution>Department of Cardiology, University of Groningen, </institution><institution>University Medical Center Groningen, </institution></institution-wrap>9700 RB Groningen, The Netherlands </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution>Medical and Population Genetics Program, </institution><institution>Broad Institute of MIT and Harvard, </institution></institution-wrap>Cambridge, 02142 MA USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Department of Internal Medicine, Division of Cardiovascular Medicine, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, 48109 MI USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Department of Computational Medicine and Bioinformatics, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, 48109 MI USA </aff><aff id="Aff7"><label>7</label>Cardiovascular Medicine Unit, Department of Medicine, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, 17176 Sweden </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2181 8870</institution-id><institution-id institution-id-type="GRID">grid.5170.3</institution-id><institution>Department of Bioinformatics, </institution><institution>Technical University of Denmark, </institution></institution-wrap>Copenhagen, 2800 Denmark </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.411843.b</institution-id><institution>Department of Cardiology, Clinical Sciences, </institution><institution>Lund University and Skåne University Hospital, </institution></institution-wrap>Lund, 22185 Sweden </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0378 8294</institution-id><institution-id institution-id-type="GRID">grid.62560.37</institution-id><institution>Department of Anesthesiology, Perioperative and Pain Medicine, </institution><institution>Brigham and Women’s Hospital, 75 Francis Street, </institution></institution-wrap>Boston, MA 02115 USA </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9206 2401</institution-id><institution-id institution-id-type="GRID">grid.267308.8</institution-id><institution>Department of Internal Medicine, Division of Medical Genetics, </institution><institution>University of Texas Health Science Center at Houston, </institution></institution-wrap>Houston, 77030 TX USA </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9894 0842</institution-id><institution-id institution-id-type="GRID">grid.410540.4</institution-id><institution>Childrens Hospital, </institution><institution>Landspitali National University Hospital of Iceland, </institution></institution-wrap>Reykjavik, 101 Iceland </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9894 0842</institution-id><institution-id institution-id-type="GRID">grid.410540.4</institution-id><institution>Department of Surgery and Cardiothoracic Surgery, </institution><institution>Landspitali National University Hospital, </institution></institution-wrap>Reykjavik, 101 Iceland </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution>Section of Cardiac Surgery, Department of Surgery, </institution><institution>Yale University School of Medicine, </institution></institution-wrap>New Haven, 06510 CT USA </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9894 0842</institution-id><institution-id institution-id-type="GRID">grid.410540.4</institution-id><institution>Department of Clinical Biochemistry, </institution><institution>Landspitali National University Hospital, </institution></institution-wrap>Reykjavik, 101 Iceland </aff><aff id="Aff16"><label>16</label>Heilsugaeslan Solvangi, Hafnarfjördur, 220 Iceland </aff><aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0640 0021</institution-id><institution-id institution-id-type="GRID">grid.14013.37</institution-id><institution>Department of Family Medicine, </institution><institution>University of Iceland, </institution></institution-wrap>Reykjavik, 101 Iceland </aff><aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0930 2361</institution-id><institution-id institution-id-type="GRID">grid.4514.4</institution-id><institution>Department of Clinical Sciences, </institution><institution>Lund University, </institution></institution-wrap>Malmö, 22185 Sweden </aff><aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0623 9987</institution-id><institution-id institution-id-type="GRID">grid.412650.4</institution-id><institution>Department of Internal Medicine, </institution><institution>Skåne University Hospital, </institution></institution-wrap>Malmö, 22185 Sweden </aff><aff id="Aff20"><label>20</label>Cardiothoracic Surgery Unit, Department of Molecular Medicine and Surgery, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, 17176 Sweden </aff><aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1516 2393</institution-id><institution-id institution-id-type="GRID">grid.5947.f</institution-id><institution>HUNT Research Centre, Department of Public Health and General Practice, </institution><institution>Norwegian University of Science and Technology, </institution></institution-wrap>Levanger, 7491 Norway </aff><aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1516 2393</institution-id><institution-id institution-id-type="GRID">grid.5947.f</institution-id><institution>K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, </institution><institution>Norwegian University of Science and Technology, </institution></institution-wrap>Trondheim, 7491 Norway </aff><aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Department of Cardiac Surgery, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, MI 48105 USA </aff><aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Frankel Cardiovascular Center, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, MI 48109 USA </aff><aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Department of Anesthesiology, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, MI 48105 USA </aff><aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Department of Biostatistics, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, MI 48109 USA </aff><aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 4656 4290</institution-id><institution-id institution-id-type="GRID">grid.416470.0</institution-id><institution>Medicine Services, Texas Heart Institute, </institution><institution>St. Luke’s Episcopal Hospital, </institution></institution-wrap>Houston, TX 77030 USA </aff><aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Department of Human Genetics, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, MI 48109 USA </aff><aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution>Massachusetts General Hospital, Harvard Medical School, </institution><institution>Broad Institute of Harvard and MIT, </institution></institution-wrap>Boston, MA 02114 USA </aff><aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution>Cardiovascular Research Center, </institution><institution>Massachusetts General Hospital, </institution></institution-wrap>Boston, MA 02114 USA </aff><aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9894 0842</institution-id><institution-id institution-id-type="GRID">grid.410540.4</institution-id><institution>Department of Internal Medicine, Division of Cardiology, </institution><institution>Landspitali National University Hospital of Iceland, </institution></institution-wrap>Reykjavik, 101 Iceland </aff><aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0640 0021</institution-id><institution-id institution-id-type="GRID">grid.14013.37</institution-id><institution>School of Engineering and Natural Sciences, </institution><institution>University of Iceland, </institution></institution-wrap>Reykjavik, 101 Iceland </aff></contrib-group><pub-date pub-type="epub"><day>7</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>7</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>987</elocation-id><history><date date-type="received"><day>26</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>31</day><month>1</month><year>2018</year></date></history><permissions><copyright-statement>© The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1"><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>Aortic valve stenosis (AS) is the most common valvular heart disease, and valve replacement is the only definitive treatment. </plain></SENT>
<SENT sid="2" pm="."><plain>Here we report a large genome-wide association (GWA) study of 2,457 Icelandic AS cases and 349,342 controls with a follow-up in up to 4,850 cases and 451,731 controls of European ancestry. </plain></SENT>
<SENT sid="3" pm="."><plain>We identify two new AS loci, on chromosome 1p21 near PALMD (rs7543130; odds ratio (OR) = 1.20, P = 1.2 × 10−22) and on chromosome 2q22 in TEX41 (rs1830321; OR = 1.15, P = 1.8 × 10−13). </plain></SENT>
<SENT sid="4" pm="."><plain>Rs7543130 also associates with bicuspid aortic valve (BAV) (OR = 1.28, P = 6.6 × 10−10) and aortic root diameter (P = 1.30 × 10−8), and rs1830321 associates with BAV (OR = 1.12, P = 5.3 × 10−3) and coronary artery disease (OR = 1.05, P = 9.3 × 10−5). </plain></SENT>
<SENT sid="5" pm="."><plain>The results implicate both cardiac developmental abnormalities and atherosclerosis-like processes in the pathogenesis of AS. </plain></SENT>
<SENT sid="6" pm="."><plain>We show that several pathways are shared by CAD and AS. </plain></SENT>
<SENT sid="7" pm="."><plain>Causal analysis suggests that the shared risk factors of Lp(a) and non-high-density lipoprotein cholesterol contribute substantially to the frequent co-occurence of these diseases. </plain></SENT>
</text></SecTag></p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2"><SecTag type="ABS"><text><SENT sid="8" pm="."><plain>Aortic valve stenosis (AS) is the most common valvular heart disease. </plain></SENT>
<SENT sid="9" pm="."><plain>Here the authors identify two new AS loci that also associate with bicuspid aortic valve, aortic root diameter and/or coronary artery disease implicating both developmental abnormalities and atherosclerosis-like processes in AS. </plain></SENT>
</text></SecTag></p></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><SecTag type="INTRO"><sec id="Sec1" sec-type="introduction"><title><text><SENT sid="10" pm="."><plain>Introduction </plain></SENT>
</text></title><p id="Par3"><text><SENT sid="11" pm="."><plain>Aortic valve stenosis (AS) is characterized by thickened and calcified valvular cusps causing left ventricular outflow obstruction. </plain></SENT>
<SENT sid="12" pm="."><plain>This progressive disease is usually graded as mild, moderate, or severe, based on the valve area and pressure gradient across the valve. </plain></SENT>
<SENT sid="13" pm="."><plain>Severe AS is a notable cause of morbidity and mortality, affecting approximately 5% of those over 70 years of age1–3, and the estimated 5-year survival in symptomatic severe AS ranges from 15 to 50% unless outflow obstruction is relieved by aortic valve replacement3. </plain></SENT>
</text></p><p id="Par4"><text><SENT sid="14" pm="."><plain>The pathogenesis of the disease remains poorly understood. </plain></SENT>
<SENT sid="15" pm="."><plain>However, several of the associated clinical risk factors of calcified aortic valve are shared by atherosclerotic disease, and immunohistochemical studies show that calcified aortic valve lesions have many characteristic features of atherosclerosis, including initial endothelial damage, oxidized lipid deposition, chronic inflammation, and calcification4. </plain></SENT>
<SENT sid="16" pm="."><plain>In addition, bicuspid aortic valve (BAV), the most common congenital cardiac malformation, when the aortic valve has two leaflets instead of three, accelerates the development of AS by decades4. </plain></SENT>
<SENT sid="17" pm="."><plain>While the prevalence of BAV is 0.5–2% in the population, BAV is found in up to half of those with severe AS5. </plain></SENT>
</text></p><p id="Par5"><text><SENT sid="18" pm="."><plain>Little is known about the genetics of AS, although a recent genome-wide association (GWA) study reported the association of rs10455872 in the LPA gene, encoding apolipoprotein(a) of lipoprotein (a) (Lp(a)), with calcification of the aortic valve, and with AS6. </plain></SENT>
<SENT sid="19" pm="."><plain>Elevated serum levels of Lp(a) have also been associated with increased risk of AS7. </plain></SENT>
<SENT sid="20" pm="."><plain>These findings are in keeping with a common pathogenic feature of AS and atherosclerosis8,9. </plain></SENT>
</text></p><p id="Par6"><text><SENT sid="21" pm="."><plain>Another genetic study recently showed that a rare p.Arg721Trp MYH6 missense variant, which was previously shown to associate with sick sinus syndrome and atrial fibrillation10,11, also associates with coarctation of the aorta, BAV, and with AS12. </plain></SENT>
</text></p><p id="Par7"><text><SENT sid="22" pm="."><plain>Here, we describe a large GWA study of AS including 2,457 cases and 349,342 controls, with follow-up in up to 4,850 AS cases and 451,731 controls. </plain></SENT>
<SENT sid="23" pm="."><plain>We examined the association of AS variants with BAV and several other cardiovascular conditions and assessed the shared genetic risk of AS and coronary artery disease (CAD). </plain></SENT>
</text></p></sec></SecTag><SecTag type="RESULTS"><sec id="Sec2" sec-type="results"><title><text><SENT sid="24" pm="."><plain>Results </plain></SENT>
</text></title><sec id="Sec3"><title><text><SENT sid="25" pm="."><plain>Novel variants associate with aortic stenosis </plain></SENT>
</text></title><p id="Par8"><text><SENT sid="26" pm="."><plain>We tested 32.5 million sequence variants for association with AS in 2,457 Icelandic cases and 349,342 controls (see Manhattan plot in Supplementary Fig. 1). </plain></SENT>
<SENT sid="27" pm="."><plain>We identified the variants by whole-genome sequencing 15,220 Icelanders, and imputed them into 151,678 chip-typed, long-range phased individuals and their close relatives13. </plain></SENT>
</text></p><p id="Par9"><text><SENT sid="28" pm="."><plain>We observed one genome-wide significant association, between AS and the intergenic variant rs7543130 (effect allele frequency (EAF) [A] = 51.2%) on chromosome 1p21 near the PALMD gene (odds ratio (OR) = 1.23; 95% confidence interval (CI): 1.15–1.31, P = 6.8 × 10−10 (significance threshold for intergenic variants set at P = 7.9 × 10−10, see Methods and ref. 14)) (Table 1). </plain></SENT>
<SENT sid="29" pm="."><plain>We noted that rs7543130 was recently reported to associate with aortic root size15 and we replicate this association in our Icelandic aortic root dimension sample (P = 1.3 × 10−8) (Table 2).Table 1Meta-analysis results for aortic valve stenosis variantsCases/controlsPALMD intergenic rs7543130 [A/C] EAF = 51.2%TEX41 intronic rs1830321 [T/C] EAF = 37.5%LPA intronic rs10455872 [G/A] EAF = 6.2%OR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P valueIceland2457/349,3421.23 (1.15–1.31)6.8 × 10−101.20 (1.12–1.28)7.6 × 10−81.4 (1.23–1.56)1.8 × 10−7Sweden (MDCS)a470/15,1621.14 (0.98–1.33)0.0921.21 (1.05–1.39)0.00801.55 (1.28–1.88)1.0 × 10−5Sweden, Stockholm318/13761.25 (0.98–1.59)0.0681.18 (0.89–1.56)0.241.19 (0.90–1.57)0.23UK Biobank1844/406,8141.25 (1.17–1.33)3.8 × 10−111.14 (1.06–1.22)1.36 × 10−41.54 (1.38–1.71)4.8 × 10−15Norway (HUNT)1546/24,2351.13 (1.05–1.22)0.00121.11 (1.02–1.20)0.0101.48 (1.28–1.71)1.0 × 10−7USA, Michigan251/25101.15 (0.96–1.39)0.131.01 (0.85–1.24)0.761.32 (0.94–1.84)0.10Combined6886/799,4391.20 (1.16–1.25)1.2 × 10−221.15 (1.11–1.20)1.8 × 10−131.46 (1.37–1.56)1.9 × 10−31Results are shown for the discovery and follow-up datasets and the joint analysis (combined). </plain></SENT>
<SENT sid="30" pm="."><plain>The effect allele is the first allele in brackets [effect allele/non-effect allele]. </plain></SENT>
<SENT sid="31" pm="."><plain>The EAF is for the Icelandic population. P value from logistic regression analysis. </plain></SENT>
<SENT sid="32" pm="."><plain>Results from the different study groups were combined using a Mantel–Haenszel modelEAF effect allele frequency, OR allelic odds ratio, 95% Cl 95% confidence interval, MDCS Malmö Diet and Cancer studya The association results for the rs10455872 variant in the MDCS included 613 cases and 28,109 controlsTable 2Association of aortic valve stenosis variants with other cardiovascular traitsBicuspid aortic valve208/25,139PALMD intergenic rs7543130 [A/C]TEX41 intronic rs1830321 [T/C]LPA intronic rs10455872 [G/A]MYH6 missense rs387906656 [A/G] p.Arg721TrpOR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P valueBicuspid aortic valve208/25,1391.26 (0.99, 1.60)0.0591.31 (1.03, 1.67)0.0251.12 (0.72, 1.75)0.618.04 (3.36, 19.22)2.8 × 10−6 Sweden-Stockholm 275/15161.27 (1.06, 1.52)0.00981.20 (0.99, 1.46)0.0631.02 (0.92, 1.12)0.77 USA-Houston 147/8641.29 (0.99, 1.67)0.0571.25 (0.97, 1.60)0.0850.96 (0.51, 1.81)0.91 USA-Boston 452/18341.27 (1.09, 1.48)0.0021.10 (0.95, 1.28)0.211.44 (1.08, 1.93)0.014 USA-Michigan 473/47301.31 (1.14, 1.51)1.2 × 10−41.00 (0.86, 1.16)0.971.19 (0.93, 1.54)0.17 Combined BAV 1555/33,8831.28 (1.19, 1.39)6.6 × 10−101.12 (1.04, 1.22)5.3 × 10−31.07 (0.98, 1.16)0.13Atrial septal defect708/353,0191.23 (1.07, 1.42)3.9 × 10−31.22 (1.06, 1.41)5.9 × 10−31.15 (0.87, 1.52)0.323.17 (1.47, 6.81)3.2 × 10−3Ventricular septal defect902/357,4281.23 (1.07, 1.42)4.8 × 10−31.04 (0.90, 1.21)0.591.14 (0.84, 1.53)0.414.40 (2.14, 9.07)5.7 × 10−5Coronary artery disease37,782/318,8451.00 (0.97, 1.02)0.741.05 (1.03, 1.08)9.3 × 10−51.28 (1.21, 1.34)2.4 × 10−221.21 (1.00, 1.48)0.056Phenotype (qtl) N β (SE)P valueβ (SE)P valueβ (SE)P valueβ (SE)P valueAortic root diameter19,5130.065 (0.01)1.3 × 10−8−0.017 (0.02)0.16−0.052 (0.02)0.020−0.068 (0.08)0.40Association of aortic valve stenosis variants with cardiovascular phenotypes is shown for Icelandic samples. </plain></SENT>
<SENT sid="33" pm="."><plain>Follow-up and joint analysis (combined BAV) is also provided for the association with BAV. </plain></SENT>
<SENT sid="34" pm="."><plain>The effect allele is the first allele in brackets [effect allele/non-effect allele]. </plain></SENT>
<SENT sid="35" pm="."><plain>The effect (β) for aortic root diameter is given in standardized units. </plain></SENT>
<SENT sid="36" pm="."><plain>Logistic (cc) or linear (qtl) regression analyses were used for association testing. </plain></SENT>
<SENT sid="37" pm="."><plain>Results from the different study groups were combined using a Mantel–Haenszel modelCc case–control, Qtl quantitative trait, OR allelic odds ratio, 95% Cl 95% confidence interval, BAV bicuspid aortic valve, SE standard error </plain></SENT>
</text></p><p id="Par10"><text><SENT sid="38" pm="."><plain>We tested the top seven common and low-frequency variants in the discovery GWA scan, including rs7543130, in up to 4,850 AS cases and 451,731 controls from Sweden, Norway, United Kingdom, and the United States (Table 1, Supplementary Data 1). </plain></SENT>
<SENT sid="39" pm="."><plain>The joint analysis showed a robust association between AS and rs7543130 (OR = 1.20; 95% CI: 1.16–1.25; P = 1.2 × 10−22) as well as rs1830321 (EAF[T] = 37.5%) intronic to TEX41, a non-protein coding gene on chromosome 2q22 (OR = 1.15; 95% CI: 1.11–1.20, P = 1.8 × 10−13) (Table 1). </plain></SENT>
</text></p><p id="Par11"><text><SENT sid="40" pm="."><plain>We replicated the reported association of the intronic LPA variant6 rs10455872 with AS in Iceland and the follow-up sample sets (combined OR = 1.46; 95% CI: 1.37–1.56, P = 1.9 × 10−31) (Table 1). </plain></SENT>
<SENT sid="41" pm="."><plain>In contrast, we did not find association with variants implicating osteogenic and calcium signaling pathway genes, previously reported to suggestively associate with AS16 (P &gt; 0.05 in Iceland and UK Biobank). </plain></SENT>
</text></p><p id="Par12"><text><SENT sid="42" pm="."><plain>We tested the association of the two novel AS variants and the LPA variant with a subset of Icelandic AS cases who had undergone aortic valve replacement, representing those with severe AS. </plain></SENT>
<SENT sid="43" pm="."><plain>Although less significant, likely due to smaller sample size, the effect sizes were not significantly different from those for all AS (Supplementary Data 2). </plain></SENT>
</text></p></sec><sec id="Sec4"><title><text><SENT sid="44" pm="."><plain>Aortic stenosis variants and cardiovascular phenotypes </plain></SENT>
</text></title><p id="Par13"><text><SENT sid="45" pm="."><plain>We tested the rs7543130 near PALMD, rs1830321 in TEX41, and the LPA rs10455872, for association with BAV, a major risk factor for AS4,5, in 1,555 cases and 33,883 controls from Iceland, Sweden, and the United States. </plain></SENT>
<SENT sid="46" pm="."><plain>Both of the novel AS variants associate with BAV and the rs7543130 association was genome-wide significant (OR = 1.28; 95% CI: 1.19–1.39; P = 6.6 × 10−10; OR = 1.12, 95% CI: 1.04–1.22, P = 5.3 × 10−3 for rs1830321). </plain></SENT>
<SENT sid="47" pm="."><plain>The LPA rs10455872 does not associate with BAV (Table 2). </plain></SENT>
</text></p><p id="Par14"><text><SENT sid="48" pm="."><plain>Table 2 also shows the association of the rare p.Arg721Trp MYH6 missense variant rs387906656 (EAF = 0.34%) with the risk of BAV (OR = 8.04; 95% CI: 3.36–19.22; P = 2.8 × 10−6). </plain></SENT>
<SENT sid="49" pm="."><plain>This variant was previously shown to associate with sick sinus syndrome and atrial fibrillation10,11, and was recently reported also to associate with coarctation of the aorta, BAV, and AS (OR = 2.65; 95% CI: 1.78–3.96; P = 1.8 × 10−6)12. </plain></SENT>
<SENT sid="50" pm="."><plain>The effect size on BAV is substantially greater than that for AS (P = 0.023), suggesting that the AS risk conferred by this variant is mediated through BAV. </plain></SENT>
</text></p><p id="Par15"><text><SENT sid="51" pm="."><plain>Next, we examined the association of the AS variants with several other cardiovascular diseases in Icelandic data. </plain></SENT>
<SENT sid="52" pm="."><plain>In line with the BAV association of p.Arg721Trp in MYH6, rs7543130, and rs1830321, all three variants associate with ventricular defects and/or atrial septal defects (P &lt; 0.006) (Table 2 and Supplementary Data 2). </plain></SENT>
</text></p><p id="Par16"><text><SENT sid="53" pm="."><plain>Like the LPA variant, rs1830321 in TEX41 associates with CAD in Iceland (OR = 1.05, 95% CI:1.03–1.08; P = 9.3 × 10−5), but the MYH6 missense variant and rs7543130 near PALMD do not (Table 2 and Supplementary Data 2). </plain></SENT>
<SENT sid="54" pm="."><plain>The TEX41 rs1830321 is in linkage disequilibrium (LD) with a known GWA CAD variant rs2252641 at the same locus (R2 = 0.80)17. </plain></SENT>
</text></p><p id="Par17"><text><SENT sid="55" pm="."><plain>Given that several atherosclerosis risk factors have been associated with AS6,18,19, we tested the novel AS variants for association with the traditional cardiovascular risk factors and observed a nominally significant association (P &lt; 0.02) between rs1830321 and systolic and diastolic blood pressure in Iceland (Supplementary Data 3) and in data from the UK Biobank (<ext-link ext-link-type="uri" xlink:href="https://biobankengine.stanford.edu/search">https://biobankengine.stanford.edu/search#</ext-link>). </plain></SENT>
</text></p></sec><sec id="Sec5"><title><text><SENT sid="56" pm="."><plain>Shared genetic risk factors with CAD </plain></SENT>
</text></title><p id="Par18"><text><SENT sid="57" pm="."><plain>The frequent comorbidity of CAD and AS20, together with the similarities in histopathology4, suggest shared genetic predisposition. </plain></SENT>
<SENT sid="58" pm="."><plain>Therefore, we tested 71 CAD variants21,22 for association with AS, both individually (Supplementary Data 4 and Table 3) and as a weighted genetic risk score (CAD-GRS-all) (Table 4). </plain></SENT>
<SENT sid="59" pm="."><plain>We excluded from this analysis the LPA variant rs10455872 and rs1830321 in TEX41 that associate genome-wide significantly with both CAD and AS.Table 3Coronary artery disease variants and aortic root size variants that associate with aortic valve stenosisPrimary associationLocusChr.Coding effectRs nameEA/other alleleOR (95% CI)P value P het  I 2 CAD CELSR2/PSRC1 1Downstream geneRs646776T/C1.11 (1.05–1.18)3.4 × 10−40.820CAD LPA 6Missense (p.Ile1891Met)Rs3798220C/T1.55 (1.33–1.81)2.1 × 10−80.40CAD SH2B3 12Missense (p.Trp60Arg)Rs3184504C/T0.91 (0.87–0.96)1.6 × 10−40.940Aortic root size CFDP1 a 16IntronicRs17696696G/T1.07 (1.03–1.11)1.3 × 10−40.05560.5CAD ANGPTL4 b 19Missense (p.Glu40Lys)Rs116843064A/G0.77 (0.68–0.88)9.5 × 10−50.368.6Shown are CAD variants and aortic root size variants that associate with AS. </plain></SENT>
<SENT sid="60" pm="."><plain>A total of 71 CAD and 11 aortic root size variants from genome-wide association studies were tested (primary association). </plain></SENT>
<SENT sid="61" pm="."><plain>The CELSR2/PSRC1, LPA, and SH2B3 variants were tested in 4,301 AS cases and 756,156 controls from Iceland and the UK Biobank. </plain></SENT>
<SENT sid="62" pm="."><plain>Results from the different study groups were combined using a Mantel–Haenszel modelP values for the combined analyses are providedCAD coronary artery disease, AS aortic valve stenosis, Chr.: chromosome, EA effect allele, OR odds ratio, Phet: P value for heterogeneity between study groups, I2: heterogeneity I2 statistics for the combined analysisa The CFDP1 variant was tested in 6,416 cases and 784,277 controls (additional samples from Sweden-Stockholm, Norway-HUNT, and the USA, Michigan)b The ANGPTL4 variant was tested in 6,886 cases and 799,439 controls (same samples as for CFDP1 plus samples from Sweden-MDCS)Table 4The association of coronary artery disease genetic risk score with aortic valve stenosisIcelandUK BiobankIceland + UK Biobank combined β P value β P valueβ (95% CI)P valueCAD-GRS-allCAD0.775.2 × 10−1530.76&lt;10−3000.76 (0.73–0.79)&lt;10−300.AS0.290.000270.287.2 × 10−60.28 (0.19–0.38)7.5 × 10−9.ASadj.CAD0.030.62−0.050.45−0.01 (−0.10, 0.08)0.83CAD-GRS-lipCAD0.891.4 × 10−360.927.8 × 10−990.91 (0.84–0.99)1.4 × 10−134.AS1.052.3 × 10−90.993.8 × 10−111.02 (0.79–1.24)5.1 × 10−19.ASadj.CAD0.771.5 × 10−50.606.6 × 10−50.67 (0.45–0.90)5.1 × 10−9CAD-GRS-non-lipCAD0.736.3 × 10−1200.724.3 × 10−2930.73 (0.69–0.78)&lt;10−300.AS0.140.0740.140.0480.14 (0.04–0.24)0.0076.ASadj.CAD−0.110.15−0.180.0088−0.15 (−0.25, −0.05)0.0036CAD-GRS-all (based on 71 reported CAD variants). </plain></SENT>
<SENT sid="63" pm="."><plain>CAD-GRS-lip (based on 14 CAD variants with reported association with LDL cholesterol (or non HDLcholesterol), or variants at the LPA locus. </plain></SENT>
<SENT sid="64" pm="."><plain>GRS-non-lip (based on 57 CAD variants, the same as in CAD-GRS-all, but excluding variants in CAD-GRS-lip). </plain></SENT>
<SENT sid="65" pm="."><plain>The effects of the GRSs on CAD are shown for comparison. </plain></SENT>
<SENT sid="66" pm="."><plain>Logistic regression was used for association testing. </plain></SENT>
<SENT sid="67" pm="."><plain>Results from the different study groups were combined using a Mantel–Haenszel modelNumber of cases–controls in Iceland and UK Biobank, respectively: CAD = 17,488/124,620 and 26,384/382,294; AS = 1,591/140,517 and 1,844/406,814P value represented as &lt;10−300 is &lt;1 × 10−300GRS genetic risk score, CAD coronary artery disease, AS aortic valve stenosis </plain></SENT>
</text></p><p id="Par19"><text><SENT sid="68" pm="."><plain>In the Icelandic and UK Biobank datasets combined, four CAD variants associate with AS at a significance threshold set at P = 7.0 × 10−4 = 0.05/71. </plain></SENT>
<SENT sid="69" pm="."><plain>These are the LPA variant rs3798220 (p.Ile1891Met), rs116843064 in ANGPTL4 (p.Glu40Lys), rs646776 at the CELSR2/PSRC1 locus, and rs3184504 in SH2B3 (p. </plain></SENT>
<SENT sid="70" pm="."><plain>Trp60Arg) (Table 3 and Supplementary Data 4 and 5). </plain></SENT>
</text></p><p id="Par20"><text><SENT sid="71" pm="."><plain>Consistent with a shared genetic risk, the CAD-GRS-all associates with AS both in the Icelandic and the UK Biobank datasets (combined P = 7.5 × 10−9) (Table 4). </plain></SENT>
<SENT sid="72" pm="."><plain>However, the effect on AS is only 37% of the effect on CAD and the AS association is  not significant after adjustment for CAD diagnosis. </plain></SENT>
<SENT sid="73" pm="."><plain>Given the reported association between genetic predisposition to both elevated Lp(a) and low-density lipoprotein (LDL) cholesterol and AS6,19, we tested a subset of CAD-GRS (labeled as CAD-GRS-lip), constructed based on 14 Lp(a) and LDL cholesterol/non-high-density lipoprotein (HDL) cholesterol variants (Supplementary Data 4) for association with AS. </plain></SENT>
<SENT sid="74" pm="."><plain>The CAD-GRS-lip associated strongly with AS (P = 5.1 × 10−19) with an effect that was similar or larger than that for CAD (β = 0.91 and 1.02, for CAD and AS, respectively). </plain></SENT>
<SENT sid="75" pm="."><plain>This association with AS remained after adjusting for CAD diagnosis (P = 5.1 × 10−9) (Table 4), suggesting that the genetic predisposition to elevated Lp(a) and LDL cholesterol explains in large part the shared genetic risk between CAD and AS. </plain></SENT>
<SENT sid="76" pm="."><plain>Specifically, examining the impact of CAD-GRS-lip on the risk of AS among CAD cases shows that CAD cases with genetic predisposition to high Lp(a) or LDL/non-HDL cholesterol are at a greater risk of having AS than CAD cases without such predisposition (P = 8.5 × 10−7) (Supplementary Data 6). </plain></SENT>
<SENT sid="77" pm="."><plain>In contrast, the complementary subset of CAD-GRS-all (CAD-GRS-non-lip), in which the Lp(a) and LDL/non-HDL cholesterol variants are excluded, associates with less risk of AS after adjusting for CAD status (P = 0.0036) (Table 4). </plain></SENT>
</text></p></sec><sec id="Sec6"><title><text><SENT sid="78" pm="."><plain>Aortic root size variants and aortic stenosis </plain></SENT>
</text></title><p id="Par21"><text><SENT sid="79" pm="."><plain>Given the known association of rs7543130[A] on chromosome 1p21 with increased aortic root dimension15 and the recognized relationship between BAV and aortopathy5,23, we excluded known or suspected BAV cases from our echocardiogram database and re-examined the association of this variant with aortic root size. </plain></SENT>
<SENT sid="80" pm="."><plain>The association with aortic root size remained in this data (β = 0.062, P = 4.4 × 10−8) (Supplementary Data 2). </plain></SENT>
</text></p><p id="Par22"><text><SENT sid="81" pm="."><plain>We then tested 11 other reported aortic root size variants15 for association with AS in Icelandic and UK Biobank datasets (Supplementary Data 7). </plain></SENT>
<SENT sid="82" pm="."><plain>One of these variants, rs17696696[G] intronic to CFDP1, associates with AS in these samples and was thus tested in additional 2,115 AS cases and 28,121 controls; the joint analysis yielded OR = 1.07, 95% CI: 1.03–1.11, P = 0.00013 (Table 3). </plain></SENT>
<SENT sid="83" pm="."><plain>A correlated variant rs4888378 (R2 = 0.98) has been reported to associate with carotid intima–media thickness and with the risk of CAD24. </plain></SENT>
<SENT sid="84" pm="."><plain>We also observed a previously unreported genome-wide significant association with CAD in Iceland and the UK Biobank data (combined OR for rs17696696[G] = 1.05, 95% CI: 1.03–1.07, P = 1.4 × 10–10). </plain></SENT>
<SENT sid="85" pm="."><plain>The AS and CAD risk allele of rs17696696[G] in CFDP1 associates with smaller aortic root diameter. </plain></SENT>
<SENT sid="86" pm="."><plain>None of the other AS variants associated with aortic root size (Table 2). </plain></SENT>
</text></p></sec><sec id="Sec7"><title><text><SENT sid="87" pm="."><plain>Candidate causal variants and genes </plain></SENT>
</text></title><p id="Par23"><text><SENT sid="88" pm="."><plain>Attempting to identify candidate causal variants and genes at the PALMD and TEX41 loci, we first looked for association of the AS variants with expression quantitative trait loci (eQTL) using the Genotype-Tissue Expression dataset25. </plain></SENT>
<SENT sid="89" pm="."><plain>Assessment of 44 diverse human tissues from adults indicated association of rs1830321 with TEX41 expression, albeit limited to thyroid tissue, but no eQTLs were observed for rs7543130. </plain></SENT>
</text></p><p id="Par24"><text><SENT sid="90" pm="."><plain>To further investigate potential functional relevance of the two AS variants, we mapped variants in LD (R2 &gt; 0.5) with rs7543130 near PALMD and rs1830321 in TEX41 to regulatory regions in heart and aorta tissue samples using public data from the NIH Roadmap Epigenomics Consortium26,27. </plain></SENT>
<SENT sid="91" pm="."><plain>Subsequently, we used chromatin interaction maps28 for aorta and left and right ventricular heart tissue samples to look for interactions between the regulatory regions, to which AS risk variants mapped, and gene promoters. </plain></SENT>
</text></p><p id="Par25"><text><SENT sid="92" pm="."><plain>At the PALMD locus, four variants (rs11166276, rs6702619, rs1890753, and rs2392040) mapped to three distinct regulatory regions annotated as enhancers and poised promoter (Fig. 1a, upper panel). </plain></SENT>
<SENT sid="93" pm="."><plain>Multiple chromatin interactions were observed for the regulatory regions harboring these four variants in left ventricular samples. </plain></SENT>
<SENT sid="94" pm="."><plain>Notably, only the region harboring rs1890753 (R2 = 0.97 with rs7543130) interacted with promoters of genes (Fig. 1a, lower panel). </plain></SENT>
<SENT sid="95" pm="."><plain>Thus, rs1890753 represents the candidate causal variant at the chromosome 1p21 locus, by directly interacting with the promoters of PALMD, SNX7, PLPPR5, and PLPPR4, and the non-coding RNAs, LOC100129620 and LOC101928270. </plain></SENT>
<SENT sid="96" pm="."><plain>In fetal heart tissue, a poised promoter state is found at the rs1890753 locus (Fig. 1a, upper panel).Fig. 1Chromatin interactions between regulatory regions harboring candidate causal variants at the PALMD and TEX41 loci. </plain></SENT>
<SENT sid="97" pm="."><plain>Chromatin states indicative of regulatory regions for the aortic valve stenosis locus on chromosomes 1p21 (a) and 2q22 (b) are shown for heart and aorta tissue samples. </plain></SENT>
<SENT sid="98" pm="."><plain>Different types of regulatory states are indicated with distinct colors shown at the top of the figure. </plain></SENT>
<SENT sid="99" pm="."><plain>EnhA (Enhancer Active), EnhW (Enhancer Weak), PromUp/Dn (Chromatin marks characteristic of a promoter region found upstream or downstream of TSS), DNase (DNase, nucleosome-free/open chromatin region), PromP (Promoter poised region, marked simultaneously as active and repressed, poised for activation during development), TssA (Transcription Start Site, Activated), and Repr (Repressive marks, heterochromatin). </plain></SENT>
<SENT sid="100" pm="."><plain>Vertical gray lines indicate the variants found in LD (R2 &gt; 0.50) with a rs7543130 (*) (N = 19) or b rs1830321 (+) (N = 50). </plain></SENT>
<SENT sid="101" pm="."><plain>Variants found to overlap with regulatory regions in any of the five tissues are marked up and indicated as red vertical lines. </plain></SENT>
<SENT sid="102" pm="."><plain>Long-range chromatin interactions in left ventricle tissue samples are shown for a the region harboring rs1890753 on chromosome 1p21 with red curved lines, including interactions to promoters for PALMD, PLPPR4, PLPPR5, DPH5 and SNX7, LOC100129620 and LOC101928270, and for b regions harboring rs13028626, rs6749506, rs2252654, rs4662414, and rs13408842 that directly interact with the promoter regions of ZEB2, GTDC1, ZEB2-AS1, LINC01412 and TEX41 </plain></SENT>
</text></p><p id="Par26"><text><SENT sid="103" pm="."><plain>At the TEX41 locus, five variants in LD with rs1830321 overlapped with four distinct regulatory regions (Fig. 1b, upper panel). </plain></SENT>
<SENT sid="104" pm="."><plain>Chromatin interaction mapping in left ventricular tissue identified the regulatory regions harboring all five variants (rs13028626, rs6749506, rs2252654, rs4662414, and rs13408842) in direct contact to the promoter region of ZEB2, and the non-coding RNAs ZEB2-AS1 and LINC01412 (Fig. 1b, lower panel). </plain></SENT>
<SENT sid="105" pm="."><plain>In addition, the rs13408842 region directly interacted with the promoter of GTDC1 and the non-coding RNA genes TEX41 and LOC101928386. </plain></SENT>
<SENT sid="106" pm="."><plain>Pairwise correlations (R2) between the five variants and the lead variant rs1830321 ranged from 1.0 for rs13028626, to 0.61 for rs2252654. </plain></SENT>
</text></p><p id="Par27"><text><SENT sid="107" pm="."><plain>Chromatin interactions between the regulatory regions harboring candidate causal variants at the PALMD and TEX41 loci were much less frequent in right ventricular tissue and aorta, compared with the left ventricle, and none overlapped with gene promoters (Supplementary Fig. 2). </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="Sec8" sec-type="discussion"><title><text><SENT sid="108" pm="."><plain>Discussion </plain></SENT>
</text></title><p id="Par28"><text><SENT sid="109" pm="."><plain>Through a large GWA study, we have discovered two common AS variants on chromosomes 1p21 near PALMD and 2q22 in TEX41, and replicated the previously reported AS variant in LPA6. </plain></SENT>
<SENT sid="110" pm="."><plain>Like the rare AS variant in MYH612, both of the novel AS variants also associate with BAV and congenital cardiac septal defects. </plain></SENT>
<SENT sid="111" pm="."><plain>The chromosome 2q22 variant also associates with CAD risk. </plain></SENT>
</text></p><p id="Par29"><text><SENT sid="112" pm="."><plain>Given that BAV is a major risk factor for AS, and that the MYH6 and chromosome 1p21 variants have substantially greater effects on BAV than on AS, it may be postulated that the AS risk conferred by these variants is mediated through BAV. </plain></SENT>
<SENT sid="113" pm="."><plain>However, as we have limited information on whether AS occured on the background of bicuspid or tricuspid valve, we were not able to determine whether these variants associate with AS in the absence of BAV. </plain></SENT>
</text></p><p id="Par30"><text><SENT sid="114" pm="."><plain>Interestingly, the AS and BAV risk allele of rs7543130 near PALMD also associates with increased aortic root size. </plain></SENT>
<SENT sid="115" pm="."><plain>The relationship between BAV and aortopathy is well recognized and several studies suggest that the dilation of the proximal ascending aorta results from changes in flow secondary to the presence of BAV5,23,29. </plain></SENT>
<SENT sid="116" pm="."><plain>This raises the question whether the effect of chromosome 1p21 variant on aortic root size can be explained by its association with BAV. </plain></SENT>
<SENT sid="117" pm="."><plain>However, our results indicate that the variant’s impact on aortic root size is not merely a consequence of BAV, since excluding BAV cases from the analysis had minimal effect on the association. </plain></SENT>
<SENT sid="118" pm="."><plain>We also note that the MYH6 missense variant has a large effect on BAV but no effect on aortic root size. </plain></SENT>
<SENT sid="119" pm="."><plain>We did not find a consistent relationship between genetic associations with risk of AS and aortic root size, but found that one additional aortic root size variant, rs17696696 intronic to CFDP1, associates with AS. </plain></SENT>
</text></p><p id="Par31"><text><SENT sid="120" pm="."><plain>We demonstrate that this new AS variant, rs17696696 in CFDP1, associates genome-wide significantly with CAD, like rs1830321 near TEX41 and the LPA rs10455872 (ref. 6). </plain></SENT>
<SENT sid="121" pm="."><plain>Further, we found that four other CAD variants associate with AS, supporting the notion that there may be a cause shared by CAD and AS. </plain></SENT>
<SENT sid="122" pm="."><plain>However, contesting a generalized common pathophysiology, causal analysis suggests that only some genetic pathways are shared by CAD and AS, and that the risk of both diseases conferred by Lp(a) and LDL/non-HDL cholesterol levels contributes substantially to the frequent co-occurence of these two diseases. </plain></SENT>
</text></p><p id="Par32"><text><SENT sid="123" pm="."><plain>These results support the assumption that lowering Lp(a) and non-HDL cholesterol levels might slow or prevent progression of AS. </plain></SENT>
<SENT sid="124" pm="."><plain>However, in a randomized trial of 1,873 patients with mild-to-moderate AS who received statin plus ezetimibe therapy or placebo, active therapy did not reduce the composite outcome of combined aortic valve events and ischemic events during a median follow-up of 52.2 months30. </plain></SENT>
<SENT sid="125" pm="."><plain>It remains conceivable that non-HDL cholesterol lowering therapy implemented earlier in the disease process could affect development of AS. </plain></SENT>
<SENT sid="126" pm="."><plain>Other potential therapeutic interventions such as Lp(a) lowering among those with high Lp(a) levels need to be explored. </plain></SENT>
</text></p><p id="Par33"><text><SENT sid="127" pm="."><plain>Although we cannot establish how the AS variants at PALMD and TEX41 affect the pathogenesis of disease, chromatin conformational experiments provide clues about potential mechanisms. </plain></SENT>
<SENT sid="128" pm="."><plain>These experiments show folding of chromatin such that distinct regulatory regions harboring variants in high LD with the lead AS variants, physically interact with several gene promoters, suggesting several candidate causal genes at both loci. </plain></SENT>
<SENT sid="129" pm="."><plain>Interestingly, in line with an impact during fetal development, a poised promoter state was found in fetal heart tissue for a candidate causal variant rs1890753 at chromosome 1p21. </plain></SENT>
<SENT sid="130" pm="."><plain>Poised promoters are considered to be involved in the expression of developmental genes allowing for a rapid response to differentiation signals. </plain></SENT>
</text></p><p id="Par34"><text><SENT sid="131" pm="."><plain>At the TEX41 locus, we note that ZEB2, one of the genes suggested through chromatin interaction studies, is a strong biological candidate. </plain></SENT>
<SENT sid="132" pm="."><plain>ZEB2 is a DNA-binding transcriptional repressor that interacts with activated SMADs, the transducers of tumor growth factor-β (TGFβ) signaling. </plain></SENT>
<SENT sid="133" pm="."><plain>TGFβs are known to play a role in cardiac development and in several aspects of cardiovascular physiology ranging from the effect on cardiomyocyte and vascular smooth muscle, and renal control of blood pressure31. </plain></SENT>
</text></p><p id="Par35"><text><SENT sid="134" pm="."><plain>In summary, we discovered two AS variants on chromosomes 1p21 and 2q22. </plain></SENT>
<SENT sid="135" pm="."><plain>Associations of these and two previously reported AS variants with BAV, other congenital heart defects, aortic root size, and CAD, involve both cardiac developmental abnormalities and atherogenesis-like processes in the pathogenesis of AS. </plain></SENT>
<SENT sid="136" pm="."><plain>Further, we demonstrate that four CAD variants and one aortic root size variant associate with AS. </plain></SENT>
<SENT sid="137" pm="."><plain>While our genetic causal analysis does not support a generalized sharing of genetic risk between CAD and AS, it indicates that the shared risk factors of Lp(a) and non-HDL cholesterol contribute substantially to the frequent co-occurence of these diseases. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="Sec9" sec-type="materials|methods"><title><text><SENT sid="138" pm="."><plain>Methods </plain></SENT>
</text></title><sec id="Sec10"><title><text><SENT sid="139" pm="."><plain>deCODE discovery study subjects </plain></SENT>
</text></title><p id="Par36"><text><SENT sid="140" pm="."><plain>The Icelandic AS sample set included all patients diagnosed in the years 1983–2016 with AS at Landspitali – The National University Hospital (LUH) in Reykjavik, the only tertiary referral center in Iceland. </plain></SENT>
<SENT sid="141" pm="."><plain>Case status was assigned based on ICD-10 codes I35.0 or I35.2 for discharge diagnoses, or the relevant NOMESCO classification of surgical procedure codes FMA, FMSA, FMD or FMSD, and subcodes). </plain></SENT>
<SENT sid="142" pm="."><plain>A total of 2,609 cases were identified and of those 2,457 had available genotypes and were included in the analysis. </plain></SENT>
<SENT sid="143" pm="."><plain>The controls included 349,342 population controls from the Icelandic genealogical database and individuals recruited through different genetic studies at deCODE genetics. </plain></SENT>
<SENT sid="144" pm="."><plain>The study was approved by the Icelandic Data Protection Authority and the National Bioethics Committee of Iceland (approval no. VSNb2015030022/03.01 with amendments). </plain></SENT>
<SENT sid="145" pm="."><plain>All participating subjects donating biological samples signed informed consents. </plain></SENT>
<SENT sid="146" pm="."><plain>Personal identities of the participants and biological samples were encrypted by a third-party system approved and monitored by the Icelandic Data Protection Authority. </plain></SENT>
</text></p><p id="Par37"><text><SENT sid="147" pm="."><plain>The deCODE genetics phenotype database contains extensive medical information on various diseases and traits. </plain></SENT>
<SENT sid="148" pm="."><plain>Cardiovascular phenotypes used for the purpose of the study included CAD (N = 37,782)32, heart failure (N = 10,480), ischemic stroke (N = 8,948)33, atrial fibrillation (N = 13,471)34, sick sinus syndrome (N = 3,310)10, high-degree atrioventricular block (N = 1,303), BAV (N = 208), atrial septal defect (N = 708), ventricular septal defect (N = 902), coarctation of aorta (N = 119), thoracic aortic aneurysm (TAA) and dissection (N = 500), hypertension (N = 54,974), type 2 diabetes (N = 11,448)35, and aortic root diameter (N = 19,506). </plain></SENT>
<SENT sid="149" pm="."><plain>The heart failure, high-degree atrioventricular block, coarctation of aorta, TAA and dissection, atrial septal defect, and ventricular septal defect sample sets were based on discharge diagnoses from LUH. </plain></SENT>
<SENT sid="150" pm="."><plain>Hypertension diagnoses were obtained from the Primary Health Care Clinics of the Reykjavik area, or from LUH. </plain></SENT>
<SENT sid="151" pm="."><plain>The BAV sample set included individuals with a documentation of BAV in an echocardiographic report from LUH between 1994 and 2015. </plain></SENT>
<SENT sid="152" pm="."><plain>Measurements of aortic root diameter were obtained from a database of 53,122 echocardiograms from 27,460 individuals performed at LUH between 1994 and 2015. </plain></SENT>
<SENT sid="153" pm="."><plain>Non-HDL cholesterol measurements (N = 136,326) were obtained from three of the largest clinical laboratories in Iceland: (i) LUH (hospitalized and ambulatory patients); (ii) the Laboratory in Mjódd, Reykjavík (ambulatory patients); and (iii) Akureyri Hospital, Regional Hospital in North Iceland, Akureyri (hospitalized and ambulatory patients)32. </plain></SENT>
<SENT sid="154" pm="."><plain>Blood pressure measurements (N = 125,647) were obtained from the Primary Health Care Clinics of the Reykjavik area. </plain></SENT>
<SENT sid="155" pm="."><plain>Measurements were adjusted for sex, year of birth, and age at measurement, and were subsequently standardized to have a normal distribution. </plain></SENT>
</text></p></sec><sec id="Sec11"><title><text><SENT sid="156" pm="."><plain>Whole-genome sequencing and imputation </plain></SENT>
</text></title><p id="Par38"><text><SENT sid="157" pm="."><plain>This study is based on whole-genome sequence data from 15,220 Icelanders participating in various disease projects at deCODE genetics. </plain></SENT>
<SENT sid="158" pm="."><plain>In addition, 151,677 Icelanders have been genotyped using Illumina SNP chips and genotype probabilities for untyped relatives are calculated based on Icelandic genealogy. </plain></SENT>
<SENT sid="159" pm="."><plain>The sequencing was done using Illumina standard TruSeq methodology to a mean depth of 35× (SD 8)13. </plain></SENT>
<SENT sid="160" pm="."><plain>Autosomal single-nucleotide polymorphisms (SNPs) and INDEL’s were identified using the Genome Analysis Toolkit version 3.4.036. </plain></SENT>
<SENT sid="161" pm="."><plain>Information about haplotype sharing was used to improve variant genotyping, taking advantage of the fact that all sequenced individuals had also been chip-typed and long-range-phased37. </plain></SENT>
</text></p></sec><sec id="Sec12"><title><text><SENT sid="162" pm="."><plain>Genotype imputation information </plain></SENT>
</text></title><p id="Par39"><text><SENT sid="163" pm="."><plain>The informativeness of genotype imputation (imputation information) was estimated by the ratio of the variance of imputed expected allele counts and the variance of the actual allele counts:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\frac{{{\rm Var}(E(\theta |{\rm chip}\,{\rm data}))}}{{{\rm Var}(\theta )}},$$\end{document}Var(E(θ∣chipdata))Var(θ),where θ is the allele count. </plain></SENT>
<SENT sid="164" pm="."><plain>Here, Var(E(θ|chip data)) is estimated by the observed variance in the imputed expected counts and Var(θ) was estimated by p(1−p), where p is the allele frequency. </plain></SENT>
</text></p></sec><sec id="Sec13"><title><text><SENT sid="165" pm="."><plain>Gene and variant annotation </plain></SENT>
</text></title><p id="Par40"><text><SENT sid="166" pm="."><plain>Variants were annotated using Ensembl release 80 and Variant Effect Predictor version 2.838. </plain></SENT>
<SENT sid="167" pm="."><plain>A total of 32.5 million variants passed the quality threshold and were imputed into 151,677 Icelanders who had been genotyped using Illumina chips. </plain></SENT>
</text></p></sec><sec id="Sec14"><title><text><SENT sid="168" pm="."><plain>Adjusting for relatedness </plain></SENT>
</text></title><p id="Par41"><text><SENT sid="169" pm="."><plain>To account for inflation in test statistics due to cryptic relatedness and stratification, we applied the method of LD score regression39. </plain></SENT>
<SENT sid="170" pm="."><plain>With a set of 1.1 M variants, we regressed the χ2 statistics from our GWA scan against LD score and used the intercept as a correction factor. </plain></SENT>
<SENT sid="171" pm="."><plain>The LD scores were downloaded from an LD score database (<ext-link ext-link-type="uri" xlink:href="ftp://atguftp.mgh.harvard.edu/brendan/1k_eur_r2_hm3snps_se_weights.RDS">ftp://atguftp.mgh.harvard.edu/brendan/1k_eur_r2_hm3snps_se_weights.RDS</ext-link>; accessed 23 June 2015). </plain></SENT>
</text></p></sec><sec id="Sec15"><title><text><SENT sid="172" pm="."><plain>Thresholds for genome-wide significance </plain></SENT>
</text></title><p id="Par42"><text><SENT sid="173" pm="."><plain>The threshold for genome-wide significance was corrected for multiple testing with a weighted Bonferroni adjustment using as weights the enrichment of variant classes with predicted functional impact among association signals14. </plain></SENT>
<SENT sid="174" pm="."><plain>With 32,463,443 sequence variants being tested, the weights given in Sveinbjornsson et al.14 were rescaled to control the family-wise error rate. </plain></SENT>
<SENT sid="175" pm="."><plain>This yielded significance thresholds of 2.6 × 10−7 for high-impact variants (N = 8,464), 5.1 × 10−8 for moderate-impact variants (N = 149,983), 4.6 × 10−9 for low-impact variants (N = 2,283,889), 2.3 × 10−9 for other variants in Dnase I hypersensitivity sites (N = 3,913,058) and 7.9 × 10−10 for other variants (N = 26,108,039). </plain></SENT>
</text></p></sec><sec id="Sec16"><title><text><SENT sid="176" pm="."><plain>Association analysis </plain></SENT>
</text></title><p id="Par43"><text><SENT sid="177" pm="."><plain>Logistic or linear regression were used to test for the association of SNPs with binary or quantitative traits, respectively, treating disease status or quantitative trait as the response and allele counts from direct genotyping or expected genotype counts from imputation as covariates. </plain></SENT>
<SENT sid="178" pm="."><plain>To account for inflation in test statistics due to cryptic relatedness and stratification, we applied the method of LD score regression39. </plain></SENT>
<SENT sid="179" pm="."><plain>The estimated correction factor for AS based on LD score regression was 1.19 for the additive model. </plain></SENT>
</text></p></sec><sec id="Sec17"><title><text><SENT sid="180" pm="."><plain>Genetic risk score </plain></SENT>
</text></title><p id="Par44"><text><SENT sid="181" pm="."><plain>Weighted GRS for CAD (CAD-GRS-all) was generated based on previously reported CAD effect estimates (logOR) (see Supplementary Data 4). </plain></SENT>
<SENT sid="182" pm="."><plain>Variants used for the CAD-GRS-lip included a subset of variants in CAD-GRS that associated with non-HDL cholesterol (P &lt; 1 × 10−8) in the Icelandic dataset, or are located at the LPA locus. </plain></SENT>
<SENT sid="183" pm="."><plain>The two LPA locus variants included in CAD-GRS-lip associate with lipoprotein(a) at P &lt; 8 × 10−90 in Iceland. </plain></SENT>
</text></p></sec><sec id="Sec18"><title><text><SENT sid="184" pm="."><plain>Genetic association replication studies </plain></SENT>
</text></title><p id="Par45"><text><SENT sid="185" pm="."><plain>The Malmo Diet and Cancer Study (MDCS) is a community-based prospective cohort of middle-aged individuals from Southern Sweden. </plain></SENT>
<SENT sid="186" pm="."><plain>In total, 30,447 subjects attended a baseline exam in 1991–1996 when they filled out a questionnaire, underwent anthropometric measurements, and donated peripheral venous blood samples40. </plain></SENT>
<SENT sid="187" pm="."><plain>Prevalent or incident cases of AS were ascertained from nationwide hospital registers with high validity as described previously19. </plain></SENT>
<SENT sid="188" pm="."><plain>Genome-wide genotyping of single-nucleotide variants was performed using the Illumina Human Omni Express Exome BeadChip kit. </plain></SENT>
<SENT sid="189" pm="."><plain>Genotyping was performed in a nested case-cohort design including 15,362 subjects with complete data, of which 470 cases with incident AS. </plain></SENT>
<SENT sid="190" pm="."><plain>The SNP rs10455872 was genotyped in the entire cohort, with genotypes available in 28,722 subjects, including 613 cases with incident AS. </plain></SENT>
<SENT sid="191" pm="."><plain>Association with incident AS was tested in a case–control analysis utilizing logistic regression under an additive inheritance model adjusted for age and sex. </plain></SENT>
<SENT sid="192" pm="."><plain>Case–control matching was performed in SAS v9.4 with the greedy algorithm, matching 1 AS case to 1 population-based controls for sex, baseline age (&lt;3 years age difference), year of baseline visit (within 3 years from visit), and requiring at least equal follow-up in controls. </plain></SENT>
<SENT sid="193" pm="."><plain>All participants were of European ancestry, confirmed by multidimensional scaling of genome-wide data. </plain></SENT>
<SENT sid="194" pm="."><plain>Informed consent was obtained from all participants and the study was approved by the Ethics Committee of Lund University, Sweden. </plain></SENT>
</text></p><p id="Par46"><text><SENT sid="195" pm="."><plain>Patients from the greater Stockholm area with AS, BAV, or TAA were recruited as a part of the ASAP (the Advanced Study of Aortic Pathology) and Artist studies. </plain></SENT>
<SENT sid="196" pm="."><plain>The ASAP cohort consists of 429 patients undergoing aortic valve surgery at the Karolinska University Hospital (Stockholm, Sweden)29,41. </plain></SENT>
<SENT sid="197" pm="."><plain>The samples were genotyped on Illumina 610wQuad beadchips and approximately 588,400 SNPs were provided after quality control (QC). </plain></SENT>
<SENT sid="198" pm="."><plain>The Artist cohort consists of 406 samples genotyped with Omni-2.5 Quad beadchips on 2,443,180 SNPs. </plain></SENT>
<SENT sid="199" pm="."><plain>Imputation was performed using Impute2 from 1000G phase1 v3. </plain></SENT>
<SENT sid="200" pm="."><plain>Samples from the POLCA/Olivia cohorts were used as controls (a total of 1,295 individuals). </plain></SENT>
<SENT sid="201" pm="."><plain>POLCA consists of healthy 50-year-old men, free from coronary heart disease, recruited at random using the population registry. </plain></SENT>
<SENT sid="202" pm="."><plain>The POLCA samples were genotyped on Illumina 610kwQuad. </plain></SENT>
<SENT sid="203" pm="."><plain>The Olivia comprises both men and women with an age distribution 33–80 years. </plain></SENT>
<SENT sid="204" pm="."><plain>In Olivia, 670 control samples were genotyped on illumina 1M genotyping arrays. </plain></SENT>
<SENT sid="205" pm="."><plain>The vast majority of included control samples are of Scandinavian ancestry. </plain></SENT>
<SENT sid="206" pm="."><plain>Association analysis was performed using SNPTEST, with age, sex, and first 10 principal components as covariates. </plain></SENT>
<SENT sid="207" pm="."><plain>The study was approved by the Human Research Ethics Committee at Karolinska Institutet (ASAP study, ethical approval number 2006/784-31/1; Artist cohort, 2008/1771-31; POLCA/Olivia control samples, 03-491), Stockholm, Sweden. </plain></SENT>
</text></p><p id="Par47"><text><SENT sid="208" pm="."><plain>The Norwegian Nord-Trøndelag Health Study (HUNT) is a population-based health survey conducted in the county of Nord-Trøndelag, Norway. </plain></SENT>
<SENT sid="209" pm="."><plain>Individuals were included at three different time points during approximately 20 years (HUNT1 (1984–1986), HUNT2 (1995–1997), and HUNT3 (2006–2008))42. </plain></SENT>
<SENT sid="210" pm="."><plain>At each time point, the entire adult population (≥20 years) was invited to participate by completing questionnaires, attending clinical examinations, and interviews. </plain></SENT>
<SENT sid="211" pm="."><plain>Taken together, the health studies include information from over 120,000 different individuals from Nord-Trøndelag. </plain></SENT>
<SENT sid="212" pm="."><plain>Biological samples including DNA have been collected for approximately 70,000 participants. </plain></SENT>
<SENT sid="213" pm="."><plain>AS was defined based on ICD-10 codes collected from local hospitals and out-patient clinics between 1999 and 2016. </plain></SENT>
<SENT sid="214" pm="."><plain>Cases were defined as individual with one or more ICD-10 codes specific for AS (“I35.0” or “I35.2”), whereas controls were all individuals without a code specific for AS. </plain></SENT>
<SENT sid="215" pm="."><plain>In total, 1,546 cases with AS and 24,235 controls genotyped with Illumina HumanCoreExome arrays were analyzed. </plain></SENT>
<SENT sid="216" pm="."><plain>Association analysis were conducted using EPACTS-3.3. </plain></SENT>
<SENT sid="217" pm="."><plain>The SNP-phenotype associations were modeled using the Firth Bias-Corrected Logistic Likelihood Ratio Test43, assuming an additive genetic model for genotyped markers and imputed genotypes. </plain></SENT>
<SENT sid="218" pm="."><plain>Models were adjusted for sex, birth year, genotyping batch, and four principal components (PCs). </plain></SENT>
<SENT sid="219" pm="."><plain>PCs were computed using PLINK. </plain></SENT>
<SENT sid="220" pm="."><plain>Individuals of non-European ancestry, based on principal components analysis (PCA) were excluded from the study. </plain></SENT>
<SENT sid="221" pm="."><plain>Additional filters applied to the analysis included minor allele count ≥10 and imputation r2 ≥ 0.3. </plain></SENT>
<SENT sid="222" pm="."><plain>Participation in the HUNT Study is based on informed consent, and the study has been approved by the Data Inspectorate and the Regional Ethics Committee for Medical Research in Norway. </plain></SENT>
</text></p><p id="Par48"><text><SENT sid="223" pm="."><plain>In the years 2006–2010, the UK Biobank study recruited 502,647 individuals aged 37–76 years from across the country. </plain></SENT>
<SENT sid="224" pm="."><plain>All participants provided information regarding their health and lifestyle via touch screen questionnaires, consented to physical measurements, and agreed to have their health followed. </plain></SENT>
<SENT sid="225" pm="."><plain>They also provided blood, urine, and saliva samples for future analysis. </plain></SENT>
<SENT sid="226" pm="."><plain>UK Biobank has ethical approval from the Northwest Multi-Center Research Ethics Committee, and informed consent was obtained from all participants. </plain></SENT>
<SENT sid="227" pm="."><plain>Genotype imputation data was available for 487,409 individuals (May 2017 release), of which 408,658 were used in the analysis. </plain></SENT>
<SENT sid="228" pm="."><plain>The 408,658 individuals were selected as self-reported white British with similar genetic ancestry based on principal component analysis and with consistent reported and genetically determined gender. </plain></SENT>
<SENT sid="229" pm="."><plain>AS was defined according to ICD-10 codes I35.0 and I35.2, based on diagnoses codes a participant has had recorded across all their episodes in hospital, and CAD was defined as the codes I20.0, I21, I22, I25.0, I25.1, I25.2, and I25.9. </plain></SENT>
<SENT sid="230" pm="."><plain>The case–controls analysis was done using SNPTEST v2.5.244 and the association with the GRS was tested using R v3.4.145. </plain></SENT>
<SENT sid="231" pm="."><plain>In both cases, the analysis was adjusted for age, gender, and 20 principle components. </plain></SENT>
<SENT sid="232" pm="."><plain>To adjust for relatedness and remaining population stratification the P values were adjusted using genomic control adjustment, with adjustment factors λg estimated based on association analysis of 155,000 unrelated common variants. </plain></SENT>
<SENT sid="233" pm="."><plain>The estimated λg's were 1.023, 1.088, 1.029, and 1.013 for the analysis of AS, CAD, AS restricted to CAD and AS excluding CAD, respectively. </plain></SENT>
</text></p><p id="Par49"><text><SENT sid="234" pm="."><plain>In the University of Michigan and Cardiovascular Health Improvement Study, we collected DNA from consented individuals with BAV from the Frankel Cardiovascular Center at the University of Michigan as part of the University of Michigan BAV registry or the Cardiovascular Health Improvement Project (CHIP). </plain></SENT>
<SENT sid="235" pm="."><plain>Patients were typically seen in clinic for aortic valve replacement or aortic aneurysm. </plain></SENT>
<SENT sid="236" pm="."><plain>DNA was isolated from peripheral blood lymphocytes. </plain></SENT>
<SENT sid="237" pm="."><plain>Four hundred and seventy-three BAV cases, 251 AS cases, and 809 TAA cases were successfully collected and genotyped. </plain></SENT>
<SENT sid="238" pm="."><plain>We identified potential controls from a surgical-based biobank, the Michigan Genomics Initiative (MGI), that were genotyped with the same GWAS array as cases. </plain></SENT>
<SENT sid="239" pm="."><plain>After excluding those with aortic disease, we performed age matching by requiring controls to have a birth year within −5 and +10 years of the case. </plain></SENT>
<SENT sid="240" pm="."><plain>From the available controls in the appropriate age and sex category, we selected the best ethnic match for each case and repeated the greedy algorithm until a control was selected for each case. </plain></SENT>
<SENT sid="241" pm="."><plain>We repeated the entire process so that 10 controls were selected for each AS and BAV case and 5 controls for each TAA case. </plain></SENT>
<SENT sid="242" pm="."><plain>All MGI research subjects provided informed consent. </plain></SENT>
<SENT sid="243" pm="."><plain>We performed genotyping using a GWAS+exome chip array (Illumina HumanCoreExome). </plain></SENT>
<SENT sid="244" pm="."><plain>To avoid any potential batch effects, cases and controls were genotyped using the same array in the same genotyping center (Sequencing and Genotyping core at the University of Michigan). </plain></SENT>
<SENT sid="245" pm="."><plain>Genotype calling was performed using GenTrain version 2.0 in GenomeStudio V2011.1 (Illumina) using identical cluster files for cases and controls. </plain></SENT>
<SENT sid="246" pm="."><plain>Samples with &lt;98% genotype calls, evidence of gender discrepancy, and duplicates as well as individuals with non-European ancestry identified by plotting the first 10 genotype-driven principal components were excluded from further analysis. </plain></SENT>
<SENT sid="247" pm="."><plain>We performed variant-level QC by excluding variants that met any of the following criteria; variants with a cluster separation score &lt;0.3, &lt;98% genotype call rate, or deviation from Hardy–Weinberg equilibrium (P &lt; 1 × 10−5). </plain></SENT>
<SENT sid="248" pm="."><plain>We phased the autosomal genotype data using SHAPEIT246 and imputed variants from the Haplotype Reference Panel v147 using minimac348,49. </plain></SENT>
<SENT sid="249" pm="."><plain>We excluded poorly imputed variants with imputation R2 &lt; 0.3. </plain></SENT>
<SENT sid="250" pm="."><plain>We performed single-variant association testing for BAV, TAA, and AS status using the Wald test based on logistic regression with age, sex, and the first four principal components as covariates using the EPACTS software (URL: <ext-link ext-link-type="uri" xlink:href="http://csg.sph.umich.edu//kang/epacts/">http://csg.sph.umich.edu//kang/epacts/</ext-link>) for imputed dosages. </plain></SENT>
<SENT sid="251" pm="."><plain>All repository projects utilized for this study are approved by the University of Michigan, Medical School, Institutional Review Board, and informed consent was obtained from study participants. </plain></SENT>
</text></p><p id="Par50"><text><SENT sid="252" pm="."><plain>In the BAVCon consortium, 452 sporadic self-reported Caucasian BAV cases were genotyped using the Illumina Omni-2.5 platform. </plain></SENT>
<SENT sid="253" pm="."><plain>One thousand eight hundred and thirty-four self-reported Caucasian population controls from the Framingham Heart Study genotyped using the Omni5 platform. </plain></SENT>
<SENT sid="254" pm="."><plain>Caucasian ancestry was further identified using PCA to detect clusters, filter outliers, and filter-related individuals both before and after merging cases and controls for association analysis. </plain></SENT>
<SENT sid="255" pm="."><plain>Principal components were included as covariates in association analysis. </plain></SENT>
<SENT sid="256" pm="."><plain>Further QC of the genotype data from both cohorts was performed using GenomeStudio and PLINK. </plain></SENT>
<SENT sid="257" pm="."><plain>After QC, we imputed additional genotypes against the 1,000 genomes reference (Phase 3) using IMPUTE2 to yield 7,913,553 genetic markers for an additive logistic regression model, adjusted for gender and age. </plain></SENT>
<SENT sid="258" pm="."><plain>This study has been approved by Partner’s in HealthCare Human Research Committee, and informed consent was obtained from study participants. </plain></SENT>
</text></p><p id="Par51"><text><SENT sid="259" pm="."><plain>In the University of Texas Health Science Center, 765 patients of European descent with TAA or aortic dissections, were enrolled and genotyped50. </plain></SENT>
<SENT sid="260" pm="."><plain>A subset of these patients had BAV, N = 147. </plain></SENT>
<SENT sid="261" pm="."><plain>The study included 864 controls from US National Institute of Neurological Disorders and Stroke (NINDS)51. </plain></SENT>
<SENT sid="262" pm="."><plain>We imputed additional genotypes against 1,000 genomes reference (Phase 3), and for association analysis, we used additive logistic regression model accounting for gender and principal components51. </plain></SENT>
<SENT sid="263" pm="."><plain>Subjects of non-European ancestry according to multidimensional scaling were removed from the analysis. </plain></SENT>
<SENT sid="264" pm="."><plain>This study has been approved by Committee for the Protection of Human Subjects at UT Health Science Center at Houston, and informed consent was obtained from study participants. </plain></SENT>
</text></p></sec><sec id="Sec19"><title><text><SENT sid="265" pm="."><plain>Identification of candidate causal variants and genes </plain></SENT>
</text></title><p id="Par52"><text><SENT sid="266" pm="."><plain>Epigenome data from the NIH Roadmap Epigenome Mapping Consortium (<ext-link ext-link-type="uri" xlink:href="http://egg2.wustl.edu/roadmap/data/byFileType/chromhmmSegmentations/ChmmModels/imputed12marks/jointModel/final/catMat/hg19_chromHMM_imputed25.gz">http://egg2.wustl.edu/roadmap/data/byFileType/chromhmmSegmentations/ChmmModels/imputed12marks/jointModel/final/catMat/hg19_chromHMM_imputed25.gz</ext-link>) for 11 histone marks analyzed by chromatin immunoprecipitation with sequencing, together with open chromatin regions analyzed by DNase-seq, integrated into 25 discrete chromatin states through ChromHMM were downloaded26. </plain></SENT>
<SENT sid="267" pm="."><plain>Lead variants and those found in LD (R2 &gt; 0.5) within the AS loci were then annotated for chromatin states involving regulatory functions, that is, EnhA (Active enhancer elements), EnhW (Weak enhancer elements), EnhTx (Enhancer marks coupled with transcription-associated histone marks), DNAse (Open chromatin configuration), TssA (Active transcription start site), PromUp/D (Regions upstream or downstream of promoter), PromP (Poised promoter), PromBiv (Bivalent promoters), Het (Heterochromatin), ReprPC (Polycomb-group repressed) while omitting states indicative of transcription status only (Tx3′, Tx5′, Tx, TxWk) or states characteristic of zinc-finger protein genes (ZNF/Rpts). </plain></SENT>
</text></p><p id="Par53"><text><SENT sid="268" pm="."><plain>High-throughput 3C analysis (Hi-C) data for right ventricular and left ventricular tissue and aorta were obtained from an online repository: Functional Mapping and Annotation of Genome-Wide Association Studies (FUMA GWAS: <ext-link ext-link-type="uri" xlink:href="http://fuma.ctglab.nl/">http://fuma.ctglab.nl/</ext-link>)52. </plain></SENT>
<SENT sid="269" pm="."><plain>It uses public datasets compiled by Schmitt et al.28 in order to identify structural interactions of enhancers with genes (Hi-C compendium: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87112">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE87112</ext-link>) </plain></SENT>
</text></p><p id="Par54"><text><SENT sid="270" pm="."><plain>Gorpipe53 was employed to query the data and then imported into R for further analysis and plotting making use of base functions (R 3.4.1). </plain></SENT>
<SENT sid="271" pm="."><plain>The Hi-C data are binned into intervals of 40 kb which are indicated as gray horizontal lines in lower panels of Fig. 1a, b, and their midpoints were then used to draw arcs from one midpoint to another for interactions at false-discovery rate &lt;1 × 10−10. </plain></SENT>
<SENT sid="272" pm="."><plain>Intersection between chromatin interaction intervals and promoters was based on Refseq annotated transcription start sites. </plain></SENT>
</text></p></sec><sec id="Sec20"><title><text><SENT sid="273" pm="."><plain>Data availability </plain></SENT>
</text></title><p id="Par55"><text><SENT sid="274" pm="."><plain>The Icelandic population WGS data has been deposited at the European Variant Archive under accession code PRJEB8636. </plain></SENT>
<SENT sid="275" pm="."><plain>The authors declare that the data supporting the findings of this study are available within the article, its Supplementary Data files and upon request. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material"><title><text><SENT sid="276" pm="."><plain>Electronic supplementary material </plain></SENT>
</text></title><sec id="Sec21"><p><text><SENT sid="277" pm="."><plain>Supplementary Information Peer Review File Description of Additional Supplementary Files Supplementary Data 1 Supplementary Data 2 Supplementary Data 3 Supplementary Data 4 Supplementary Data 5 Supplementary Data 6 Supplementary Data 7 </plain></SENT>
</text></p></sec></sec></SecTag></body><back><fn-group><fn><p><text><SENT sid="278" pm="."><plain>Electronic supplementary material </plain></SENT>
</text></p><p><text><SENT sid="279" pm="."><plain>Supplementary Information accompanies this paper at 10.1038/s41467-018-03252-6. </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="280" pm="."><plain>Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. </plain></SENT>
</text></p></fn></fn-group><SecTag type="ACK_FUND"><ack><title>Acknowledgements</title><p><text4fund><text><SENT sid="281" pm="."><plain>We are grateful to all study subjects for their valuable participation in our research. </plain></SENT>
<SENT sid="282" pm="."><plain>We thank our collaborators and the staff at deCODE genetics core facilities and the Research Service Center for their important contribution to this work. </plain></SENT>
<SENT sid="283" pm="."><plain>We would like to thank all UK Biobank participants, staff, and investigators. </plain></SENT>
<SENT sid="284" pm="."><plain>This research has been conducted using the UK Biobank Resource under Application Number 15293. </plain></SENT>
<SENT sid="285" pm="."><plain>We thank all participants of the Cardiovascular Health Improvement Project (CHIP) and BAV registry at the University of Michigan for their contribution to research. </plain></SENT>
<SENT sid="286" pm="."><plain>We appreciate the valuable efforts from the CHIP and BAV registry collection team. </plain></SENT>
<SENT sid="287" pm="."><plain>The University of Michigan Health System—Cardiovascular Health Improvement Project was supported by the Frankel Cardiovascular Center. </plain></SENT>
<SENT sid="288" pm="."><plain>We appreciate the Aikens Fund for Aortic Research (to C.J.W., B.Y.) and McKay research award for supporting this project (to B.Y.). </plain></SENT>
<SENT sid="289" pm="."><plain>B.Y. is supported by American Association of Thoracic Surgery (AATS) Graham Foundation and Thoracic Surgery Foundation of Research and Education (TSFRE). </plain></SENT>
<SENT sid="290" pm="."><plain>C.J.W. is supported by HL109946, HL130705, and HL127564. </plain></SENT>
<SENT sid="291" pm="."><plain>W.Z. is supported by the Rackham Predoctoral Fellowship of the University of Michigan. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="SUPPL"><notes notes-type="author-contribution"><title>Author contributions</title><p>A.H., H.H., D.G., G.Thl., U.Th., and K.S. designed the study and interpreted the results. A.H., H.H., S.G., and G.Thl. drafted the manuscript. A.H., G.Thl., D.G. O.A.S., and V.T. performed bioinformatic and statistical analysis in the discovery study and joint data analysis. H.H., I.J., R.B.Th., Th.B., V.S., G.O., I.O., E.L.S., R.D., T.G., A.G., and G.Th. collected and characterized Icelandic phenotype data. P.A., O.M., J.G.S., P.E, A.Ha, A.F.-C., L.Fr., K.H, C.N.-C., D.M., D.G., B.Y., W.H., C.J.W., M.L., C.M.B, G.A., M.M., and S.C.B. designed and managed individual studies and characterized phenotype data. A.M., L.Fo., J.B.N., N.V., S.P., W.Z., and M.H., performed statistical analyses for individual replication studies. A.H., G.Th., H.H., D.G., G.Thl, U.Th., K.S., S.G., O.A.S., V.T., I.J., R.B.Th., Th.B., V.S., G.O., I.O., E.L.S., R.D., T.G., A.G., P.A., O.M., J.G.S., P.E, A.Ha, A.F.-C., L.Fr., K.H, C.N.-C., D.M., D.G., B.Y., W.H., C.J.W., M.L., C.M.B, G.A., M.M., S.C.B., A.M., L.Fo., J.B.N., N.V., S.P., W.Z., and M.H. reviewed the manuscript. K.S. supervised the study.</p></notes></SecTag><notes notes-type="COI-statement"><sec id="FPar1"><title>Competing interests</title><p id="Par56">A.H., S.G., G.Thl, O.A.S., V.T., R.B.Th, I.J., Th.B., V.S., G.Th., U.Th., D.G., H.H., and K.S. are employed by deCODE Genetics/Amgen Inc. All the other authors declare no competing financial interests.</p></sec></notes><SecTag type="REF"><ref-list id="Bib1"><title>References</title><ref id="CR1"><text><SENT sid="292" pm="."><plain>1.DanielsenRAspelundTHarrisTBGudnasonVThe prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: the AGES–Reykjavík studyInt. </plain></SENT>
<SENT sid="293" pm="."><plain>J. </plain></SENT>
<SENT sid="294" pm="."><plain>Cardiol.201417691692210.1016/j.ijcard.2014.08.053<?supplied-pmid 25171970?>25171970 </plain></SENT>
</text></ref><ref id="CR2"><text><SENT sid="295" pm="."><plain>2.OsnabruggeRLJAortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling studyJ. </plain></SENT>
<SENT sid="296" pm="."><plain>Am. </plain></SENT>
<SENT sid="297" pm="."><plain>Coll. </plain></SENT>
<SENT sid="298" pm="."><plain>Cardiol.2013621002101210.1016/j.jacc.2013.05.015<?supplied-pmid 23727214?>23727214 </plain></SENT>
</text></ref><ref id="CR3"><text><SENT sid="299" pm="."><plain>3.Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESCVahanianAGuidelines on the management of valvular heart disease (version 2012)Eur. </plain></SENT>
<SENT sid="300" pm="."><plain>Heart J.2012332451249610.1093/eurheartj/ehs10922922415 </plain></SENT>
</text></ref><ref id="CR4"><text><SENT sid="301" pm="."><plain>4.DweckMRBoonNANewbyDECalcific aortic stenosisJ. </plain></SENT>
<SENT sid="302" pm="."><plain>Am. </plain></SENT>
<SENT sid="303" pm="."><plain>Coll. </plain></SENT>
<SENT sid="304" pm="."><plain>Cardiol.2012601854186310.1016/j.jacc.2012.02.093<?supplied-pmid 23062541?>23062541 </plain></SENT>
</text></ref><ref id="CR5"><text><SENT sid="305" pm="."><plain>5.SiuSCSilversidesCKBicuspid aortic valve diseaseJ. </plain></SENT>
<SENT sid="306" pm="."><plain>Am. </plain></SENT>
<SENT sid="307" pm="."><plain>Coll. </plain></SENT>
<SENT sid="308" pm="."><plain>Cardiol.2010552789280010.1016/j.jacc.2009.12.068<?supplied-pmid 20579534?>20579534 </plain></SENT>
</text></ref><ref id="CR6"><text><SENT sid="309" pm="."><plain>6.ThanassoulisGGenetic associations with valvular calcification and aortic stenosisN. </plain></SENT>
<SENT sid="310" pm="."><plain>Engl. </plain></SENT>
<SENT sid="311" pm="."><plain>J. </plain></SENT>
<SENT sid="312" pm="."><plain>Med.201336850351210.1056/NEJMoa1109034<?supplied-pmid 23388002?>23388002 </plain></SENT>
</text></ref><ref id="CR7"><text><SENT sid="313" pm="."><plain>7.ArsenaultBJLipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective mendelian randomization study and replication in a case–control cohortCirc. </plain></SENT>
<SENT sid="314" pm="."><plain>Cardiovasc. </plain></SENT>
<SENT sid="315" pm="."><plain>Genet.2014730431010.1161/CIRCGENETICS.113.000400<?supplied-pmid 24704946?>24704946 </plain></SENT>
</text></ref><ref id="CR8"><text><SENT sid="316" pm="."><plain>8.ClarkeRGenetic variants associated with Lp(a) lipoprotein level and coronary diseaseN. </plain></SENT>
<SENT sid="317" pm="."><plain>Engl. </plain></SENT>
<SENT sid="318" pm="."><plain>J. </plain></SENT>
<SENT sid="319" pm="."><plain>Med.20093612518252810.1056/NEJMoa0902604<?supplied-pmid 20032323?>20032323 </plain></SENT>
</text></ref><ref id="CR9"><text><SENT sid="320" pm="."><plain>9.HelgadottirAApolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolismJ. </plain></SENT>
<SENT sid="321" pm="."><plain>Am. </plain></SENT>
<SENT sid="322" pm="."><plain>Coll. </plain></SENT>
<SENT sid="323" pm="."><plain>Cardiol.20126072272910.1016/j.jacc.2012.01.078<?supplied-pmid 22898070?>22898070 </plain></SENT>
</text></ref><ref id="CR10"><text><SENT sid="324" pm="."><plain>10.HolmHA rare variant in MYH6 is associated with high risk of sick sinus syndromeNat. </plain></SENT>
<SENT sid="325" pm="."><plain>Genet.20114331632010.1038/ng.781<?supplied-pmid 21378987?>21378987 </plain></SENT>
</text></ref><ref id="CR11"><text><SENT sid="326" pm="."><plain>11.ThorolfsdottirRBA missense variant in PLEC increases risk of atrial fibrillationJ. </plain></SENT>
<SENT sid="327" pm="."><plain>Am. </plain></SENT>
<SENT sid="328" pm="."><plain>Coll. </plain></SENT>
<SENT sid="329" pm="."><plain>Cardiol.2017702157216810.1016/j.jacc.2017.09.005<?supplied-pmid 29050564?>29050564 </plain></SENT>
</text></ref><ref id="CR12"><text><SENT sid="330" pm="."><plain>12.Bjornsson, T. et al. </plain></SENT>
<SENT sid="331" pm="."><plain>A rare missense mutation in MYH6 confers high risk of coarctation of the aorta. </plain></SENT>
<SENT sid="332" pm="."><plain>Preprint at <ext-link ext-link-type="uri" xlink:href="http://www.biorxiv.org/content/early/2017/08/29/180794">http://www.biorxiv.org/content/early/2017/08/29/180794</ext-link> (2017). </plain></SENT>
</text></ref><ref id="CR13"><text><SENT sid="333" pm="."><plain>13.GudbjartssonDFLarge-scale whole-genome sequencing of the Icelandic populationNat. </plain></SENT>
<SENT sid="334" pm="."><plain>Genet.20154743544410.1038/ng.3247<?supplied-pmid 25807286?>25807286 </plain></SENT>
</text></ref><ref id="CR14"><text><SENT sid="335" pm="."><plain>14.SveinbjornssonGWeighting sequence variants based on their annotation increases power of whole-genome association studiesNat. </plain></SENT>
<SENT sid="336" pm="."><plain>Genet.20164831431710.1038/ng.3507<?supplied-pmid 26854916?>26854916 </plain></SENT>
</text></ref><ref id="CR15"><text><SENT sid="337" pm="."><plain>15.WildPSLarge-scale genome-wide analysis identifies genetic variants associated with cardiac structure and functionJ. </plain></SENT>
<SENT sid="338" pm="."><plain>Clin. </plain></SENT>
<SENT sid="339" pm="."><plain>Invest.20171271798181210.1172/JCI84840<?supplied-pmid 28394258?>28394258 </plain></SENT>
</text></ref><ref id="CR16"><text><SENT sid="340" pm="."><plain>16.Guauque-OlarteSCalcium signaling pathway genes RUNX2 and CACNA1C are associated with calcific aortic valve diseaseCirc. </plain></SENT>
<SENT sid="341" pm="."><plain>Cardiovasc. </plain></SENT>
<SENT sid="342" pm="."><plain>Genet.2015881282210.1161/CIRCGENETICS.115.001145<?supplied-pmid 26553695?>26553695 </plain></SENT>
</text></ref><ref id="CR17"><text><SENT sid="343" pm="."><plain>17.CARDIoGRAMplusC4D ConsortiumDeloukasPLarge-scale association analysis identifies new risk loci for coronary artery diseaseNat. </plain></SENT>
<SENT sid="344" pm="."><plain>Genet.201345253310.1038/ng.248023202125 </plain></SENT>
</text></ref><ref id="CR18"><text><SENT sid="345" pm="."><plain>18.CarabelloBAIntroduction to aortic stenosisCirc. </plain></SENT>
<SENT sid="346" pm="."><plain>Res.201311317918510.1161/CIRCRESAHA.113.300156<?supplied-pmid 23833292?>23833292 </plain></SENT>
</text></ref><ref id="CR19"><text><SENT sid="347" pm="."><plain>19.SmithJGAssociation of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosisJAMA2014312176410.1001/jama.2014.13959<?supplied-pmid 25344734?>25344734 </plain></SENT>
</text></ref><ref id="CR20"><text><SENT sid="348" pm="."><plain>20.AndellPEpidemiology of valvular heart disease in a Swedish nationwide hospital-based register studyHeart20171031696170310.1136/heartjnl-2016-310894<?supplied-pmid 28432156?>28432156 </plain></SENT>
</text></ref><ref id="CR21"><text><SENT sid="349" pm="."><plain>21.NikpayMA comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery diseaseNat. </plain></SENT>
<SENT sid="350" pm="."><plain>Genet.2015471121113010.1038/ng.3396<?supplied-pmid 26343387?>26343387 </plain></SENT>
</text></ref><ref id="CR22"><text><SENT sid="351" pm="."><plain>22.HowsonJMMFifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanismsNat. </plain></SENT>
<SENT sid="352" pm="."><plain>Genet.2017491113111910.1038/ng.3874<?supplied-pmid 28530674?>28530674 </plain></SENT>
</text></ref><ref id="CR23"><text><SENT sid="353" pm="."><plain>23.WiltonEJahangiriMPost-stenotic aortic dilatationJ. </plain></SENT>
<SENT sid="354" pm="."><plain>Cardiothorac. </plain></SENT>
<SENT sid="355" pm="."><plain>Surg.20061710.1186/1749-8090-1-7<?supplied-pmid 16722611?>16722611 </plain></SENT>
</text></ref><ref id="CR24"><text><SENT sid="356" pm="."><plain>24.GertowKIdentification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima–media thickness and coronary artery disease riskCirc. </plain></SENT>
<SENT sid="357" pm="."><plain>Cardiovasc. </plain></SENT>
<SENT sid="358" pm="."><plain>Genet.2012565666510.1161/CIRCGENETICS.112.963660<?supplied-pmid 23152477?>23152477 </plain></SENT>
</text></ref><ref id="CR25"><text><SENT sid="359" pm="."><plain>25.MeleMThe human transcriptome across tissues and individualsScience201534866066510.1126/science.aaa0355<?supplied-pmid 25954002?>25954002 </plain></SENT>
</text></ref><ref id="CR26"><text><SENT sid="360" pm="."><plain>26.Roadmap Epigenomics ConsortiumKundajeAIntegrative analysis of 111 reference human epigenomesNature201551831733010.1038/nature1424825693563 </plain></SENT>
</text></ref><ref id="CR27"><text><SENT sid="361" pm="."><plain>27.ErnstJKellisMChromHMM: automating chromatin-state discovery and characterizationNat. </plain></SENT>
<SENT sid="362" pm="."><plain>Methods2012921521610.1038/nmeth.1906<?supplied-pmid 22373907?>22373907 </plain></SENT>
</text></ref><ref id="CR28"><text><SENT sid="363" pm="."><plain>28.SchmittADA compendium of chromatin contact maps reveals spatially active regions in the human genomeCell Rep.2016172042205910.1016/j.celrep.2016.10.061<?supplied-pmid 27851967?>27851967 </plain></SENT>
</text></ref><ref id="CR29"><text><SENT sid="364" pm="."><plain>29.JacksonVBicuspid aortic valve leaflet morphology in relation to aortic root morphology: a study of 300 patients undergoing open-heart surgeryEur. </plain></SENT>
<SENT sid="365" pm="."><plain>J. </plain></SENT>
<SENT sid="366" pm="."><plain>Cardiothorac. </plain></SENT>
<SENT sid="367" pm="."><plain>Surg.201140e11824<?supplied-pmid 21620721?>21620721 </plain></SENT>
</text></ref><ref id="CR30"><text><SENT sid="368" pm="."><plain>30.RossebøABIntensive lipid lowering with simvastatin and ezetimibe in aortic stenosisN. </plain></SENT>
<SENT sid="369" pm="."><plain>Engl. </plain></SENT>
<SENT sid="370" pm="."><plain>J. </plain></SENT>
<SENT sid="371" pm="."><plain>Med.20083591343135610.1056/NEJMoa0804602<?supplied-pmid 18765433?>18765433 </plain></SENT>
</text></ref><ref id="CR31"><text><SENT sid="372" pm="."><plain>31.AzharMTransforming growth factor beta in cardiovascular development and functionCytokine Growth Factor. </plain></SENT>
<SENT sid="373" pm="."><plain>Rev.20031439140710.1016/S1359-6101(03)00044-3<?supplied-pmid 12948523?>12948523 </plain></SENT>
</text></ref><ref id="CR32"><text><SENT sid="374" pm="."><plain>32.HelgadottirAVariants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary diseaseNat. </plain></SENT>
<SENT sid="375" pm="."><plain>Genet.20164863463910.1038/ng.3561<?supplied-pmid 27135400?>27135400 </plain></SENT>
</text></ref><ref id="CR33"><text><SENT sid="376" pm="."><plain>33.GretarsdottirSRisk variants for atrial fibrillation on chromosome 4q25 associate with ischemic strokeAnn. </plain></SENT>
<SENT sid="377" pm="."><plain>Neurol.20086440240910.1002/ana.21480<?supplied-pmid 18991354?>18991354 </plain></SENT>
</text></ref><ref id="CR34"><text><SENT sid="378" pm="."><plain>34.GudbjartssonDFVariants conferring risk of atrial fibrillation on chromosome 4q25Nature200744835335710.1038/nature06007<?supplied-pmid 17603472?>17603472 </plain></SENT>
</text></ref><ref id="CR35"><text><SENT sid="379" pm="."><plain>35.SteinthorsdottirVIdentification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetesNat. </plain></SENT>
<SENT sid="380" pm="."><plain>Genet.20144629429810.1038/ng.2882<?supplied-pmid 24464100?>24464100 </plain></SENT>
</text></ref><ref id="CR36"><text><SENT sid="381" pm="."><plain>36.McKennaAThe Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing dataGenome Res.2010201297130310.1101/gr.107524.110<?supplied-pmid 20644199?>20644199 </plain></SENT>
</text></ref><ref id="CR37"><text><SENT sid="382" pm="."><plain>37.KongADetection of sharing by descent, long-range phasing and haplotype imputationNat. </plain></SENT>
<SENT sid="383" pm="."><plain>Genet.2008401068107510.1038/ng.216<?supplied-pmid 19165921?>19165921 </plain></SENT>
</text></ref><ref id="CR38"><text><SENT sid="384" pm="."><plain>38.McLarenWDeriving the consequences of genomic variants with the Ensembl API and SNP Effect PredictorBioinformatics2010262069207010.1093/bioinformatics/btq330<?supplied-pmid 20562413?>20562413 </plain></SENT>
</text></ref><ref id="CR39"><text><SENT sid="385" pm="."><plain>39.Bulik-SullivanBKLD score regression distinguishes confounding from polygenicity in genome-wide association studiesNat. </plain></SENT>
<SENT sid="386" pm="."><plain>Genet.20154729129510.1038/ng.3211<?supplied-pmid 25642630?>25642630 </plain></SENT>
</text></ref><ref id="CR40"><text><SENT sid="387" pm="."><plain>40.SmithJGPlatonovPGHedbladBEngströmGMelanderOAtrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validityEur. </plain></SENT>
<SENT sid="388" pm="."><plain>J. </plain></SENT>
<SENT sid="389" pm="."><plain>Epidemiol.2010259510210.1007/s10654-009-9404-1<?supplied-pmid 19936945?>19936945 </plain></SENT>
</text></ref><ref id="CR41"><text><SENT sid="390" pm="."><plain>41.FolkersenLAssociation of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular diseaseCirc. </plain></SENT>
<SENT sid="391" pm="."><plain>Cardiovasc. </plain></SENT>
<SENT sid="392" pm="."><plain>Genet.2010336537310.1161/CIRCGENETICS.110.948935<?supplied-pmid 20562444?>20562444 </plain></SENT>
</text></ref><ref id="CR42"><text><SENT sid="393" pm="."><plain>42.KrokstadSCohort Profile: the HUNT Study, NorwayInt. </plain></SENT>
<SENT sid="394" pm="."><plain>J. </plain></SENT>
<SENT sid="395" pm="."><plain>Epidemiol.20134296897710.1093/ije/dys095<?supplied-pmid 22879362?>22879362 </plain></SENT>
</text></ref><ref id="CR43"><text><SENT sid="396" pm="."><plain>43.MaCBlackwellTBoehnkeMScottLJGoT2D investigators.Recommended joint and meta-analysis strategies for case–control association testing of single low-count variantsGenet. </plain></SENT>
<SENT sid="397" pm="."><plain>Epidemiol.20133753955010.1002/gepi.21742<?supplied-pmid 23788246?>23788246 </plain></SENT>
</text></ref><ref id="CR44"><text><SENT sid="398" pm="."><plain>44.MarchiniJHowieBMyersSMcVeanGDonnellyPA new multipoint method for genome-wide association studies by imputation of genotypesNat. </plain></SENT>
<SENT sid="399" pm="."><plain>Genet.20073990691310.1038/ng2088<?supplied-pmid 17572673?>17572673 </plain></SENT>
</text></ref><ref id="CR45"><text><SENT sid="400" pm="."><plain>45.R Development Core Team.R: a language and environment for statistical computingR. </plain></SENT>
<SENT sid="401" pm="."><plain>Found. </plain></SENT>
<SENT sid="402" pm="."><plain>Stat. </plain></SENT>
<SENT sid="403" pm="."><plain>Comput.20081409 </plain></SENT>
</text></ref><ref id="CR46"><text><SENT sid="404" pm="."><plain>46.DelaneauOMarchiniJZaguryJFA linear complexity phasing method for thousands of genomesNat. </plain></SENT>
<SENT sid="405" pm="."><plain>Methods2011917918110.1038/nmeth.1785<?supplied-pmid 22138821?>22138821 </plain></SENT>
</text></ref><ref id="CR47"><text><SENT sid="406" pm="."><plain>47.McCarthySA reference panel of 64,976 haplotypes for genotype imputationNat. </plain></SENT>
<SENT sid="407" pm="."><plain>Genet.2016481279128310.1038/ng.3643<?supplied-pmid 27548312?>27548312 </plain></SENT>
</text></ref><ref id="CR48"><text><SENT sid="408" pm="."><plain>48.HowieBFuchsbergerCStephensMMarchiniJAbecasisGRFast and accurate genotype imputation in genome-wide association studies through pre-phasingNat. </plain></SENT>
<SENT sid="409" pm="."><plain>Genet.20124495595910.1038/ng.2354<?supplied-pmid 22820512?>22820512 </plain></SENT>
</text></ref><ref id="CR49"><text><SENT sid="410" pm="."><plain>49.FuchsbergerCAbecasisGRHindsDA. minimac2: faster genotype imputationBioinformatics20153178278410.1093/bioinformatics/btu704<?supplied-pmid 25338720?>25338720 </plain></SENT>
</text></ref><ref id="CR50"><text><SENT sid="411" pm="."><plain>50.PrakashSKRare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissectionsAm. </plain></SENT>
<SENT sid="412" pm="."><plain>J. </plain></SENT>
<SENT sid="413" pm="."><plain>Hum. </plain></SENT>
<SENT sid="414" pm="."><plain>Genet.20108774375610.1016/j.ajhg.2010.09.015<?supplied-pmid 21092924?>21092924 </plain></SENT>
</text></ref><ref id="CR51"><text><SENT sid="415" pm="."><plain>51.LeMaireSAGenome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1Nat. </plain></SENT>
<SENT sid="416" pm="."><plain>Genet.201143996100010.1038/ng.934<?supplied-pmid 21909107?>21909107 </plain></SENT>
</text></ref><ref id="CR52"><text><SENT sid="417" pm="."><plain>52.WatanabeKTaskesenEvan BochovenAPosthumaDFunctional mapping and annotation of genetic associations with FUMANat. </plain></SENT>
<SENT sid="418" pm="."><plain>Commun.20178182610.1038/s41467-017-01261-5<?supplied-pmid 29184056?>29184056 </plain></SENT>
</text></ref><ref id="CR53"><text><SENT sid="419" pm="."><plain>53.GuðbjartssonHGORpipe: a query tool for working with sequence data based on a Genomic Ordered Relational (GOR) architectureBioinformatics2016323081308810.1093/bioinformatics/btw199<?supplied-pmid 27339714?>27339714 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
